Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2005-05-31
2005-05-31
Guzo, David (Department: 1636)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C424S093100, C424S093600, C435S320100, C435S069100, C435S455000, C435S456000, C435S457000, C536S023100, C536S023200, C536S023400, C536S023500, C536S024100
Reexamination Certificate
active
06899870
ABSTRACT:
The present invention generally relates to viral vectors and their use as expression vectors for transforming human cells, both in vitro and in vivo. More particularly, the present invention relates to adenoviral vectors containing propapoptotic genes and their use in cancer therapy.
REFERENCES:
patent: 6143291 (2000-11-01), June et al.
patent: 6194191 (2001-02-01), Zhang et al.
James W. Lillie et al, Transcription activation by the adenovirus E1a protein, nature vol. 338, Mar. 2, 1989.*
Randal J. Kaufman, Vectors Used For Expression, Methods in Enzymology, vol. 185, 1990.*
Coll et al., “Antitumor activity ofbaxandp53naked gene transfer in lung cancer: in vitro and in vivo analysis,”Human Gene Therapy, 9:2063-2074, 1998.
“One way to kill cancer: give it a cold,” www.cnn.com, pp. 1-4, May 20, 1997.
Sakakura et al., “Overexpression of bax sensitizes human breast cnacer MCF-7 cells to radiation-induced apoptosis,”Int. J. Cancer, 67:101-105, 1996.
Vogelbaum, et al., “Transfection of C6 glioma cells with thebaxgene and increased sensitivity to treatment with cytosine arabinoside,”J. Neurosurg, 88:99-105, 1998.
Chittenden et al., “Induction of apoptosis by the Bc1-2 homologue Bak,”Nature, 374:733-736, 1995.
Fang et al., “Evaluation of GLA4/TATA in vivo,”J. Biol. Chem., 273:4972-4975, 1988.
Krajewski et al., “Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bc1-2,”Am J. Pathol., 145:1323-1336, 1994.
Krajewski et al., “Immunohistochemical analysis of in vivo patterns ofBakexpression, a propoptotic member of the Bc1-2 protein family,”Cancer Res., 56:2849-2855, 1996.
McDonnell et al., “Expression of Bc1-2 oncoprotein and p53 proten accumulation in bone marrow metastases of androgen independent prostate cancer,”J. Urology, 157:569-574, 1997.
Merchant et al., “Expression of wild-type p53 simulates an increase in both Bax and Bc1-xLprotein content in HT29 cells,”Oncogene, 13:2631-2637, 1996.
Miyashita et al., “Identification of a p53-dependent negative response element in thebc1-2gene,”Cancer Res., 54:3131-3135, 1994.
Miyashita et al., “Tumor suppressor p53 is a direct transcriptional activator of the humanbaxgene,”Cell, 80:293-299, 1995.
Miyashita et al., “Tumor suppressor p53 is a regulator ofbc1-2andbaxgene expression in vitro and in vivo,”Oncogene, 9:1799-1805, 1994.
Oligino et al., “In vivo transgene activation from an HSV-based gene therapy vector by GAL4:VP16,”Gene Ther., 3:892-899, 1996.
Ouyang et al., “The BAX gene, the promoter of apoptosis, is mutated in genetically unstable cancers of the colorectum, stomach, and endometrium,”Clin. Cancer Res.4:1071-1074, 1998.
Pastorino et al., “The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition,”J. Biol. Chem.273:7770-7775, 1998.
Sakakura et al., “Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis,”Int. J. Cancer67:101-105, 1996.
Wang et al., “Posititve and negative regulation of gene expression in eukaryotic cells with an inducible transcriptional regulator,”Gene Ther., 4:432-441, 1997.
Wyllie, “Death gets a brake,”Nature, 369:272-273, 1994.
Yin et al., “Bax suppresses tumorigenesis and stimulates apoptosis in vivo,”Nature385:637-640, 1997.
Yin et al., “Heterodimierization with bax is required for Bc1-2 to repress cell death,”Curr. Top. Microbiol. Immunol., 194:331-337, 1995.
Yin et al., “BH1 and BH2 domains of Bc1-2 are required for inhibition of apoptosis and heterodimerization with Bax,”Nature, 369:321-323, 1994.
Bruckheimer Elizabeth M.
Fang Bingliang
Ji Lin
McDonnell Timothy J.
Roth Jack A.
Board of Regents , The University of Texas System
Fulbright & Jaworski
Guzo David
LandOfFree
Induction of apoptic or cytotoxic gene expression by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Induction of apoptic or cytotoxic gene expression by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Induction of apoptic or cytotoxic gene expression by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3422980